Prucalopride-N-Galactopyranoside
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

Prucalopride-N-Galactopyranoside

● Under Development

Catalogue No.:VL760028
CAS No.:N/A
Mol. Formula:C24H36ClN3O8
Mol. Weight:530.01 g/mol

Additional information on Prucalopride-N-Galactopyranoside

Parent drug

Abacavir

IUPAC Name

5-chloro-N-(1-(3-methoxypropyl)piperidin-4-yl)-4-(((2R, 3S, 4S, 5R)-3, 4, 5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)amino)-2, 3-dihydrobenzofuran-7-carboxamide

Synonyms

N/A

Description

Prucalopride-N-Galactopyranoside or 5-chloro-N-(1-(3-methoxypropyl)piperidin-4-yl)-4-(((2R,3S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)amino)-2,3-dihydrobenzofuran-7-carboxamide, it is used for treatment of chronic idiopathic constipation and is a prokinetic agent,

References

Tameez Ud Din, Asim, et al. “Clinical Efficacy and Safety Profile of Prucalopride in Chronic Idiopathic Constipation.” Cureus, 4 Apr. 2019, 10.7759/cureus.4382.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url